Regulation And Legal
Astonea Labs IPO Fund Reallocation to Damaira Pharmaceuticals
Astonea Labs discloses a ₹6.25 crore reallocation of unutilized IPO funds for a strategic investment in Damaira Pharmaceuticals.
The deviation was approved by the board on 27-Feb-2026 and shareholders
